glp-1 and afib receptor agonists myocardial metabolism in atrial fibrillation Glucagon-like peptide 1 receptor agonists:

The first cardiovascular safety trial of a GLP-1R agonist, demonstrating that lixisenatide does not augment MACE in patients with T2DM who had a recent acute coronary event

A medical consultation is important before starting treatment, especially for anyone with a history of pancreatitis, gallbladder disease, severe gastrointestinal disease, certain endocrine cancers, pregnancy, breastfeeding, complex diabetes medication use, or a personal or family history of medullary thyroid carcinoma or MEN2

GLP-1/GIP + B12 is our advanced personalized medication, carefully designed to combine the benefits of GLP-1/GIP + B12 with additional supportive ingredients

FDA (2008)

So, its important to consider what foods you eat while taking this medication

American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity